HopeStage
Back to all studies
Not Yet RecruitingNCT07306078

Methylphenidate and Response to Alcohol Cues

Medication studyAges 18–25United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 25 years.

Listed locations
GainesvilleSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: October 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
50
Sponsor
University of Florida
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 25 Years
Official registry ID
NCT07306078
Official title
Show the full official title

Attentional Ability and Resilience to Alcohol Use Disorder: Neurocognitive Mechanisms: Protocol Two

Recruitment & locations

Not yet recruiting

Gainesville

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Florida, a university.

Does this study involve medication?

Yes. The study involves medication, including Methylphenidate Pill.

Who can participate?

Listed age limits: 18 years to 25 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies